Buscar
Mostrando ítems 1-10 de 618
Novel aspects of parenchymal–mesenchymal interactions: from cell types to molecules and beyond
(Wiley, 2013-06)
Mesenchymal stem or stromal cells (MSCs) were initially isolated from the bone marrow and received their name on the basis of their ability to differentiate into multiple lineages such as bone, cartilage, fat and muscle. ...
Anti-brain protein autoantibodies are detectable in extraparenchymal but not parenchymal neurocysticercosis
(2020)
Neurocysticercosis (NC) presents a spectrum of clinical manifestations, with two broad clinical entities based on the central nervous system location of the parasite: extraparenchymal (EP-NC) and parenchymal (P-NC). In ...
Mortality in parenchymal and subarachnoid neurocysticercosis
(American Society of Tropical Medicine and Hygiene, 2021)
Neurocysticercosis (NCC) is endemic in many parts of the world, carrying significant neurological morbidity that varies according to whether lesions are located inside the cerebral parenchyma or in extraparenchymal spaces. ...
Hippocampal Atrophy/Sclerosis Is Associated with Old, Calcified Parenchymal Brain Neurocysticercosis, But Not with More Recent, Viable Infections
(American Society of Tropical Medicine and Hygiene, 2022)
Magnetic resonance images from 197 patients with calcified neurocysticercosis (NCC), 38 with viable NCC and 197 NCC-free healthy rural villagers were evaluated to compare the frequency of hippocampal atrophy/sclerosis (HAS) ...
The many facets of disseminated parenchymal brain cysticercosis: A differential diagnosis with important therapeutic implications.
(Public Library of Science, 2021)
Neurocysticercosis (NCC), the infection of the nervous system by the cystic larvae of Taenia solium, is a highly pleomorphic disease because of differences in the number and anatomical location of lesions, the viability ...
Clinical topography relationship in patients with parenchymal neurocysticercosis and seizures
(Elsevier, 2018)
OBJECTIVE: Discordances between imaging findings of parenchymal neurocysticercosis and seizure expression have been reported, and as such the possibility that neurocysticercosis and seizures may frequently coexist by chance ...
Reciprocal contribution of clinical studies and the HP10 antigen ELISA for the diagnosis of extraparenchymal neurocysticercosis.
(2018)
Abstract To evaluate diagnosis of active neurocysticercosis, paired cerebral spinal fluid (CSF) and serum samples from 24 neurocysticercosis (NCC) patients and 17 control neurological patients were assayed in the HP10 ...
Improved Diagnosis of Viable Parenchymal Neurocysticercosis by Combining Antibody Banding Patterns on Enzyme-Linked Immunoelectrotransfer Blot (EITB) with Antigen Enzyme-Linked Immunosorbent Assay (ELISA)
(American Society for Microbiology, 2022)
The diagnosis of neurocysticercosis (NCC) depends on neuroimaging and serological confirmation. While antibody detection by enzyme-linked immunoelectrotransfer blot (EITB) fails to predict viable NCC, EITB banding patterns ...
Seizure in people with newly diagnosed active or transitional neurocysticercosis
(2011-03)
Purpose: The aim of this study is to describe seizure as a presenting symptom in individuals with recently
diagnosed neurocysticercosis (NCC).
Methods: Using logistic regression, we examined the probability of having ...
Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis
(Oxford University Press, 2019)
Background: The efficacy of albendazole therapy in patients with parenchymal neurocysticercosis (NCC) is suboptimal. Plasma levels of albendazole sulfoxide (ASOX), the active metabolite of albendazole, are highly variable ...